Trevogrumab (MSTN/GDF8) - Research Grade Biosimilar
Product Specifications
Background
Trevogrumab is under investigation in clinical trial NCT02943239 (Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men) .
Immunogen
Homo sapiens / MSTN/GDF8 [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=10-725
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
REGN-1033, REGN1033, SAR-391786
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1451254-01 0.02 mg (E-Coli)
Recombinant Salmonella choleraesuis Probable inorganic polyphosphate/ATP-NAD kinase (ppnK)
Ask
View Details MBS1451254-02 0.02 mg (Yeast)
Recombinant Salmonella choleraesuis Probable inorganic polyphosphate/ATP-NAD kinase (ppnK)
Ask
View Details MBS1451254-03 0.1 mg (E-Coli)
Recombinant Salmonella choleraesuis Probable inorganic polyphosphate/ATP-NAD kinase (ppnK)
Ask
View Details 
MBS1451254-04 0.1 mg (Yeast)
Recombinant Salmonella choleraesuis Probable inorganic polyphosphate/ATP-NAD kinase (ppnK)
Ask
View Details